Guanfacine extended-release (intuniv) for ADHD.
D000284:Administration, Oral; D000293:Adolescent; D058647:Adrenergic alpha-2 Receptor Agonists / Q000008:administration & dosage / Q000009:adverse effects / Q000191:economics / Q000493:pharmacokinetics / Q000627:therapeutic use*; D001289:Attention Deficit Disorder with Hyperactivity / Q000188:drug therapy*; D002648:Child; D003692:Delayed-Action Preparations; D016527:Drug Costs; D004347:Drug Interactions; D016316:Guanfacine / Q000008:administration & dosage / Q000009:adverse effects / Q000191:economics / Q000493:pharmacokinetics / Q000627:therapeutic use*; D006801:Humans; D013607:Tablets; D016896:Treatment Outcome
D058647:Adrenergic alpha-2 Receptor Agonists; D003692:Delayed-Action Preparations; D013607:Tablets; D016316:Guanfacine